IP Library Granted Patent US 10,451,615
Granted Patent B2
US 10,451,615 · App. 14/959,699 · Granted Oct 22, 2019

Methods and devices for performing high dynamic range immunoassays

Inventors: Gregory M. Husar (Longmont, CO); Sarah Rachel Bickman (Boulder, CO); Michael J. Lochhead (Boulder, CO)
Assignee: MBio Diagnostics, Inc.
G01N33/54306G01N33/54366
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,451,615
App. No.
14/959,699
Granted
Oct 22, 2019
Kind
B2
Abstract

A method for performing a high dynamic range immunoassay includes (a) measuring a first signal from a sandwich immunoassay to detect a target analyte in a fluidic sample in a fluidic channel and a second signal from a competitive immunoassay associated with the target analyte in the same fluidic sample in the fluidic channel, and (b) determining ratio of the first signal to the second signal to provide a measure of concentration of the target analyte in the fluidic sample, wherein the measure is applicable to a high dynamic range of concentrations of the target analyte.

Claims (21)

1. A system for performing an assay on a sample, comprising:

an assay device including:

a capillary channel for containing the sample, and

a microarray immobilized to a surface of the capillary channel, the microarray including (a) a first spot including a first capture molecule for specifically binding to a target analyte in the sample as part of a sandwich immunoassay involving the first capture molecule, the target analyte, and a detect reagent in the sample, and (b) a second spot including a second capture molecule for specifically binding to the detect reagent in a competitive assay; and

an analysis module including:

an interrogation unit for measuring a first signal from the first spot and a second signal from the second spot,

a ratio calculator for calculating a ratio of the first signal to the second signal, as measured or after background subtraction, the ratio being proportional to concentration of the target analyte for a high dynamic range of concentrations of the target analyte, and

an interface for outputting the ratio as a measure of the concentration.

2. The system of claim 1 , the microarray further comprising at least one third spot including a third capture molecule for measuring background.

3. The system of claim 1 , the surface being a surface of a planar waveguide for guiding light to evanescently illuminate the microarray to read out a first fluorescence signal from the first sandwich immunoassay and a second fluorescence signal from the competitive assay.

4. The system of claim 1 ,

the capillary channel further comprising:

an inlet port for receiving the sample upstream of the microarray, and

an outlet port downstream from the microarray;

the capillary channel defining a direction of flow of the sample from an inlet port to an outlet port of the fluidic channel; and

the first spot and the second spot being placed in a row of the microarray parallel to the direction of flow.

5. The system of claim 4 , the surface being a surface of a planar waveguide for guiding light to evanescently illuminate the microarray, with equal evanescent illumination for the first spot and the second spot, to read out (a) a first fluorescence signal from the sandwich immunoassay and (b) a second fluorescence signal from the competitive assay.

6. The system of claim 5 , the row further comprising a third spot including a third molecule for measuring a background contribution to each of the first fluorescence signal and the second fluorescence signal.

7. The system of claim 1 , the target analyte being a first antigen, the detect reagent being an antibody with specific affinity for binding with the target analyte, the first capture molecule being a first antibody with specific affinity for binding with the target analyte, and the second capture molecule being a second antigen with specific affinity for binding with the detect reagent.

8. The system of claim 1 , the high dynamic range exceeding range of proportionality between the first signal and the concentration.

9. The system of claim 1 , the high dynamic range being at least four orders of magnitude.

Assignments (5)
MERGER Recorded May 19, 2025
From: MBIO DIAGNOSTICS, INC.
To: HESKA CORPORATION
Reel/Frame 071338/0695 →
MERGER Recorded May 19, 2025
From: HESKA CORPORATION
To: ANTECH DIAGNOSTICS, INC.
Reel/Frame 071338/0716 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2025
From: ANTECH DIAGNOSTICS, INC.
To: MARS, INCORPORATED
Reel/Frame 071338/0783 →
SECURITY INTEREST Recorded Feb 2, 2021
From: MBIO DIAGNOSTICS, INC. DBA LIGHTDECK DIAGNOSTICS
To: HESKA CORPORATION
Reel/Frame 055111/0089 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2016
From: HUSAR, GREGORY M.; BICKMAN, SARAH RACHEL; LOCHHEAD, MICHAEL J.
To: MBIO DIAGNOSTICS, INC.
Reel/Frame 037673/0329 →
Continuity (2)
Provisional Application 62088124 · Dec 5, 2014
Related Publication 20160161474A1 · Jun 9, 2016